Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159 USD | -1.85% | -6.24% | +28.20% |
Business Summary
Number of employees: 229
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100.0
%
| 0 | nan % | 51 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 51 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 16-04-14 | |
Suma M. Krishnan
FOU | Founder | 59 | 16-04-14 |
Ram Kamineni
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Trevor Parry
CTO | Chief Tech/Sci/R&D Officer | - | - |
George Chen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Meg Dodge
IRC | Investor Relations Contact | - | - |
Hubert Chen
PRN | Corporate Officer/Principal | - | - |
John Thomas
LAW | General Counsel | - | 21-08-31 |
Nate Rattner
AUD | Comptroller/Controller/Auditor | - | - |
John Karakkal
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Janney
BRD | Director/Board Member | 58 | 16-10-31 |
Suma M. Krishnan
FOU | Founder | 59 | 16-04-14 |
Dino Rossi
BRD | Director/Board Member | 69 | 17-05-31 |
Chief Executive Officer | 59 | 16-04-14 | |
Julian Gangolli
BRD | Director/Board Member | 66 | 19-02-28 |
Director/Board Member | 57 | 17-08-31 | |
E. Sutherland
BRD | Director/Board Member | 54 | 22-01-17 |
Director/Board Member | 66 | 21-01-03 | |
Director/Board Member | 59 | 23-03-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,514,547 | 24,871,222 ( 87.22 %) | 0 | 87.22 % |
Company contact information
Krystal Biotech, Inc.
2100 Wharton Street Suite 701
15203, Pittsburgh
+412 586 5830
http://www.krystalbio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.20% | 4.54B | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.57% | 22.2B | |
-16.53% | 21.23B | |
-8.77% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- KRYS Stock
- Company Krystal Biotech, Inc.